D&A Pharma Services Ltd - Accounts to registrar (filleted) - small 18.2

D&A Pharma Services Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.4.0.171 12277281 Board of Directors 1.11.20 31.10.21 31.10.21 false true false false false 358 39303 358 38945 358 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure122772812020-10-31122772812021-10-31122772812020-11-012021-10-31122772812019-10-22122772812019-10-232020-10-31122772812020-10-3112277281ns16:EnglandWales2020-11-012021-10-3112277281ns15:PoundSterling2020-11-012021-10-3112277281ns11:Director12020-11-012021-10-3112277281ns11:PrivateLimitedCompanyLtd2020-11-012021-10-3112277281ns11:Micro-entities2020-11-012021-10-3112277281ns11:AuditExempt-NoAccountantsReport2020-11-012021-10-3112277281ns11:FullAccounts2020-11-012021-10-3112277281ns11:Director1412020-10-3112277281ns11:Director1412020-11-012021-10-3112277281ns11:Director1412019-10-232020-10-3112277281ns11:Director1412021-10-3112277281ns11:Director1412020-10-3112277281ns6:CurrentFinancialInstruments2021-10-3112277281ns6:CurrentFinancialInstruments2020-10-3112277281ns6:Non-currentFinancialInstruments2021-10-3112277281ns6:Non-currentFinancialInstruments2020-10-3112277281ns11:RegisteredOffice2020-11-012021-10-3112277281ns11:Director22020-11-012021-10-31122772812ns11:Director22020-10-31122772812ns11:Director22019-10-22122772812ns11:Director22020-11-012021-10-31122772812ns11:Director22019-10-232020-10-31122772812ns11:Director22021-10-31122772812ns11:Director22020-10-31
REGISTERED NUMBER: 12277281 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 October 2021

for

D&A Pharma Services Ltd

D&A Pharma Services Ltd (Registered number: 12277281)






Contents of the Financial Statements
for the Year Ended 31 October 2021




Page

Balance Sheet 1


D&A Pharma Services Ltd (Registered number: 12277281)

Balance Sheet
31 October 2021

31.10.21 31.10.20
£    £    £    £   
FIXED ASSETS 132,179 53,449

CURRENT ASSETS 46,064 22,782

PREPAYMENTS AND ACCRUED INCOME 549 28,554

CREDITORS
Amounts falling due within one year (85,386 ) (57,443 )
NET CURRENT LIABILITIES (38,773 ) (6,107 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

93,406

47,342

CREDITORS
Amounts falling due after more than one
year

(88,026

)

(27,883

)

ACCRUALS AND DEFERRED INCOME (3,000 ) (3,000 )
NET ASSETS 2,380 16,459

CAPITAL AND RESERVES 2,380 16,459

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

D&A Pharma Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12277281

Registered office: High Firs
Ling Lane
Leeds
West Yorkshire
LS14 3HX

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2020 - 7 ) .

D&A Pharma Services Ltd (Registered number: 12277281)

Balance Sheet - continued
31 October 2021

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the year ended 31 October 2021 and the period ended 31 October 2020:

31.10.21 31.10.20
£    £   
Mrs A D Lee and D M Lee
Balance outstanding at start of year 358 -
Amounts advanced (39,303 ) -
Amounts repaid - 358
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (38,945 ) 358



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 9 March 2022 and were signed on its behalf by:





D M Lee - Director